MedPath

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

Phase 2
Recruiting
Conditions
Pneumococcal Disease
Interventions
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)
Registration Number
NCT06531538
Lead Sponsor
Pfizer
Brief Summary

The purpose of this study is to learn about the safety, tolerability and immune effects of a pneumococcal vaccine in toddlers.

Participants will take part in this study for approximately 6 or 8 months depending on which group they are assigned to. During this time participants will have 2 clinic visits and 1 phone visit for the 1-Dose group, or 3 clinic visits and 1 phone visit for the 2-Dose group.

At these clinic visits, participants will be asked if any side effects were experienced. The participants will also have to give blood samples during some clinic visits.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Male or female toddlers ≥12 to ≤15 months of age at the time of consent.
  • Healthy toddlers determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study.
  • Have received 3 infant doses of 20vPnC at 2, 4, and 6 months of age, with the last dose administered >56 days before enrollment into the study. Documented confirmation of receipt will be collected prior to randomization.
Exclusion Criteria
  • History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis).
  • Major known congenital malformation or serious chronic disorder.
  • Other acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the participant inappropriate for entry into this study.
  • Previous vaccination with any licensed or investigational pneumococcal vaccine (other than 20vPnC) or planned receipt during study participation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PG4 2-Dose GroupPG4Participants to receive two injections of Multivalent Pneumococcal Vaccine
20-valent pneumococcal conjugate vaccine (20vPnC)20-valent pneumococcal conjugate vaccine (20vPnC)Participants to receive a single injection of 20-valent pneumococcal conjugate vaccine (20vPnC).
PG4 1-Dose GroupPG4Participants to receive a single injection of Multivalent Pneumococcal Vaccine
Primary Outcome Measures
NameTimeMethod
Percentage of participants reporting prespecified local reactions within 7 days after each dose7 days after each dose

Prespecified local reactions (redness, swelling, and pain at the injection site) after each dose

Percentage of participants reporting Adverse Events (AEs) within 1 month after the last assigned vaccinationFrom signing of ICD to 1 month after last assigned vaccination

Adverse events occurring within 1 month after the last assigned vaccination

Percentage of participants reporting prespecified systemic events within 7 days after each dose7 days after each dose

Prespecified systemic events (fever, decreased appetite, drowsiness/increased sleep, and irritability) after each dose

Percentage of participants reporting Serious Adverse Events (SAEs) within 6 months after vaccinationFrom signing of ICD to 6 months after last assigned vaccination

SAEs occurring from Dose 1 through 6 months after the last assigned vaccination

Secondary Outcome Measures
NameTimeMethod
Pneumococcal serotype specific IgG concentrations1 month after last assigned vaccination

Pneumococcal IgG GMCs 1 month after the last assigned vaccination

Trial Locations

Locations (44)

Bluegrass Clinical Research, Inc.

🇺🇸

Louisville, Kentucky, United States

Bio-Medical Research LLC

🇺🇸

Miami, Florida, United States

Tekton Research, LLC.

🇺🇸

Beaumont, Texas, United States

Javara - Privia Medical Group Georgia - Fayetteville

🇺🇸

Fayetteville, Georgia, United States

Rophe Adult and Pediatric Medicine/SKYCRNG

🇺🇸

Union City, Georgia, United States

Clinical Research Prime

🇺🇸

Idaho Falls, Idaho, United States

Clinical Research Prime Rexburg

🇺🇸

Rexburg, Idaho, United States

The Iowa Clinic

🇺🇸

Ankeny, Iowa, United States

All Children Pediatrics

🇺🇸

Louisville, Kentucky, United States

Louisiana State University Health Sciences Shreveport - Fairfield avenue

🇺🇸

Shreveport, Louisiana, United States

Louisiana State University Health Sciences Shreveport

🇺🇸

Shreveport, Louisiana, United States

University of Maryland, Baltimore

🇺🇸

Baltimore, Maryland, United States

Ochsner/LSU Health Ambulatory Care Center

🇺🇸

Shreveport, Louisiana, United States

University of Maryland, Baltimore, Center for Vaccine Development and Global Health

🇺🇸

Baltimore, Maryland, United States

The Pediatric Center

🇺🇸

Columbia, Maryland, United States

Child Health Care Associates

🇺🇸

East Syracuse, New York, United States

The Pediatric Center of Frederick

🇺🇸

Frederick, Maryland, United States

Atrium Health - Strive Vaccine Research Clinic

🇺🇸

Charlotte, North Carolina, United States

Rochester Clinical Research, LLC

🇺🇸

Rochester, New York, United States

Cyn3rgy Research

🇺🇸

Gresham, Oregon, United States

Atrium Health-Myers Park

🇺🇸

Charlotte, North Carolina, United States

Duke Vaccine and Trials Unit

🇺🇸

Durham, North Carolina, United States

Durham Pediatrics at North Duke Street

🇺🇸

Durham, North Carolina, United States

Atrium Health-Matthews

🇺🇸

Matthews, North Carolina, United States

Javara - Wake Forest Health Network - Ford, Simpson, Lively & Rice Pediatrics

🇺🇸

Winston-Salem, North Carolina, United States

Senders Pediatrics

🇺🇸

South Euclid, Ohio, United States

Allegheny Health and Wellness Pavilion

🇺🇸

Erie, Pennsylvania, United States

Coastal Pediatric Research

🇺🇸

Summerville, South Carolina, United States

Javara - Privia Medical Group North Texas - Dallas

🇺🇸

Dallas, Texas, United States

Oak Cliff Research Company, LLC

🇺🇸

Dallas, Texas, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

PAS Research - McAllen

🇺🇸

Edinburg, Texas, United States

Mercury Clinical Research - Houston

🇺🇸

Houston, Texas, United States

DM Clinical Research

🇺🇸

Houston, Texas, United States

Pediatric Associates

🇺🇸

Houston, Texas, United States

University of Texas Medical Branch

🇺🇸

League City, Texas, United States

Kool Kids Pediatrics

🇺🇸

Houston, Texas, United States

Sunrise Pediatrics

🇺🇸

Houston, Texas, United States

North Houston Internal Medicine & Pediatric Clinic

🇺🇸

Tomball, Texas, United States

Ponce Medical School Foundation Inc.

🇵🇷

Ponce, Puerto Rico

BRCR Medical Center - Ponce

🇵🇷

Ponce, Puerto Rico

BRCR Global Puerto Rico

🇵🇷

San Juan, Puerto Rico

Caribbean Medical Research Center

🇵🇷

San Juan, Puerto Rico

Riveldi Biomedical Research and Associates - Miami Lakes

🇺🇸

Miami Lakes, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath